Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Chiesi Ventures

Investor type Venture Capital
Founders Giacomo Chiesi


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 17
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 5
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Genetics

The main department of described VC is located in the Boston. The venture was found in North America in United States.

Besides them, we counted 1 critical employee of this fund in our database.

The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. This Chiesi Ventures works on 18 percentage points less the average amount of lead investments comparing to the other organizations.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Chiesi Ventures, startups are often financed by Caixa Capital Risc, Ysios Capital, Healthequity. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Sanderling Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by Ysios Capital, Sanderling Ventures, Sambrinvest.

Among the various public portfolio startups of the fund, we may underline Minoryx Therapeutics, VelosBio, 4D Molecular Therapeutics The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Chiesi Ventures:
Typical Co-investors
Chiesi Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Chiesi Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3W Partners Missouri, Saint Louis, United States
Altos Venture Allschwil, Basel-Landschaft, Switzerland
Blue Ocean Capital Group China, Guangdong, Shenzhen
Blue Wave Innovation Capital County Dublin, Dublin, Ireland
Chartwell Investments New York, New York, United States
China Asset Management Beijing, Beijing, China
Davidson consulting Boulogne-Billancourt, France, Ile-de-France
Emergent Game Technologies Calabasas, California, United States
Estrella Roja -
GNI Group -
Invitalia Italy, Lazio, Roma
IPF Partners Luxembourg, Luxembourg
JSW Ventures India, Maharashtra, Mumbai
Kite Ventures Moscow, Moscow, Russia
Pepper Media Holding Berlin, Berlin, Germany
Sparbanksstiftelse Norrlands Riskkapitalstiftelse -
Suzhou Decheng Hongxing Touzi China, Jiangsu, Suzhou
Taiheng Touzi China, Hangzhou, Zhejiang
Verve Capital Florida, Miami, United States
Zhejiang Wanghe Touzi Guanli Gufen Youxian Gongsi China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$35M23 Jun 2021 San Francisco, California, United States

Aura Biosciences

Health Care
$80M22 Mar 2021 Cambridge, Massachusetts, United States

Reneo Pharmaceuticals

$95M09 Dec 2020 San Diego, California, United States

4D Molecular Therapeutics

Drug Discovery
$75M16 Jun 2020 California, United States


$33M07 Aug 2019 San Francisco, California, United States

Mirum Pharmaceuticals

Health Care
$120M07 Nov 2018 San Diego, California, United States

CuraSen Therapeutics

Medical Device
$54M17 Oct 2018 California, United States


$58M01 Oct 2018 -

Minoryx Therapeutics

$25M26 Sep 2018 Barcelona, Catalonia, Spain
Aura Biosciences Announces Oversubscribed $80 Million Financing

– Aura Biosciences closed an oversubscribed $80m financing.
– The financing was led by Matrix Capital Management and Surveyor Capital (a Citadel company) with participation from new investors, including Rock Springs Capital, Adage Capital Management LP and Velosity Capital.
– Existing investors Medicxi, Advent Life Sciences, Lundbeckfonden Ventures, Arix Bioscience, Chiesi Ventures, Ysios Capital and Columbus Venture Partners also participated in the round.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Chiesi Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: